TCD spin-out developing a non-surgical device to treat tricuspid regurgitation.
| Date | Round | Amount |
|---|---|---|
| Aug 2024 | Series B CroíValve closed a $16m Series B led by the MedTech and Irrus Syndicates, with existing investors and new investor IAG Capital Partners, to fund an early feasibility study of its Duo device. | $16M |